MAPK1 and thyroid tumor: Our findings in thyroid tumor cells are different from those reported in melanoma, hepatocellular carcinoma (HCC) and colorectal carcinoma (CRC) cells [18], indicating that the actions of the inhibitor on ERK dimerization likely depend on the cell type.